Penumbra (PEN) Accumulated Expenses (2014 - 2026)
Penumbra (PEN) posted quarterly Accumulated Expenses of $172.3 million for Q2 2026, up 50.6% year-over-year from $114.4 million in Q2 2025, and up 13.68% quarter-over-quarter from $151.5 million in Q1 2026.
Penumbra (PEN) Accumulated Expenses (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Accumulated Expenses for 13 consecutive years, with $172.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Accumulated Expenses rose 50.6% year-over-year to $172.3 million; the TTM figure through Jun 2026 stood at $172.3 million (up 50.6% YoY), while the FY2025 annual figure was $132.2 million, up 17.55% from the prior year.
- Accumulated Expenses rose to $172.3 million in Q2 2026 per PEN's latest filing, from $151.5 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $172.3 million in Q2 2026 and bottomed at $101.7 million in Q3 2022.
- Historically, Accumulated Expenses has averaged $115.9 million across 5 years, with a median of $108.6 million in 2023.
- Annual changes were most pronounced in 2023 — Accumulated Expenses declined 5.21% — and 2026, when it surged 50.6%.
- Penumbra's Accumulated Expenses stood at $106.3 million in 2022, then gained by 4.0% to $110.6 million in 2023, then increased by 1.7% to $112.4 million in 2024, then increased by 17.55% to $132.2 million in 2025, then surged by 30.35% to $172.3 million in 2026.
- Business Quant data shows PEN's Accumulated Expenses at $172.3 million in Q2 2026, $151.5 million in Q1 2026, and $132.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Penumbra | 12.79 Bn | 12.13 Bn | 264.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 172.27 Mn |
| Mar 31, 2026 | 151.54 Mn |
| Dec 31, 2025 | 132.16 Mn |
| Sep 30, 2025 | 124.27 Mn |
| Jun 30, 2025 | 114.39 Mn |
| Mar 31, 2025 | 112.68 Mn |
| Dec 31, 2024 | 112.43 Mn |
| Sep 30, 2024 | 105.55 Mn |
| Jun 30, 2024 | 104.07 Mn |
| Mar 31, 2024 | 106.55 Mn |
| Dec 31, 2023 | 110.56 Mn |
| Sep 30, 2023 | 104.18 Mn |
| Jun 30, 2023 | 105.61 Mn |
| Mar 31, 2023 | 105.87 Mn |
| Dec 31, 2022 | 106.30 Mn |
| Sep 30, 2022 | 101.67 Mn |
| Jun 30, 2022 | 111.41 Mn |
| Mar 31, 2022 | 105.53 Mn |
| Dec 31, 2021 | 99.80 Mn |
| Sep 30, 2021 | 93.22 Mn |